Evidence map›Paper›PMID 36248063›Full record

ArticleFuture science OA2022

The combinatory effect of scaffold topography and culture condition: an approach to nucleus pulposus tissue engineering.

Noviana Vanawati, Anggraini Barlian, Hermawan Judawisastra, Indra Wibowo

Open access · goldAbstract read
In one paragraph

Article in Future science OA, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Noviana VanawatiSchool of Life Sciences & Technology, Institut Teknologi Bandung, Bandung, West Java, 40132, Indonesia.ORCID https://orcid.org/0000-0001-7569-253X
Anggraini BarlianSchool of Life Sciences & Technology, Institut Teknologi Bandung, Bandung, West Java, 40132, Indonesia.ORCID https://orcid.org/0000-0002-0826-3134
Hermawan JudawisastraFaculty of Mechanical & Aerospace Engineering, Institut Teknologi Bandung, Bandung, West Java, 40132, Indonesia.ORCID https://orcid.org/0000-0003-2317-9931
Indra WibowoSchool of Life Sciences & Technology, Institut Teknologi Bandung, Bandung, West Java, 40132, Indonesia.ORCID https://orcid.org/0000-0001-7197-2075
Bandung Institute of Technology · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scaffold topography and culture medium conditions for human wharton's jelly mesenchymal stem cells (hWJ-MSC) are critical components of the approach to nucleus pulposus (NP) tissue engineering. Aim: To evaluate the silk fibroin (SF) scaffold topography analysis (optimal thickness and pore diameter) and to determine culture medium conditions for the growth and differentiation of hWJ-MSC. Method: hWJ-MSCs were seeded into different thicknesses and pore size diameters and grown in different concentrations of glucose, platelet rich plasma (PRP) and oxygen. The cell-seeded scaffold was evaluated for cell attachment, growth and differentiation potency. Results & discussion: The results indicated that SF scaffold with a minimum thickness 3.5 mm and pore diameter of 500 μm with cells cultured under low glucose, 10% PRP and normoxia conditions induced the growth and differentiation of hWJ-MSCs, indicated by the accumulation of glycosaminoglycans content and the presence of type II collagen, as markers of NP-like cells.

Indexed as

Human Wharton's jelly mesenchymal stem cellshypoxialow oxygen concentrationmicroenvironmentnucleus pulposus tissue engineeringplatelet rich plasmasilk fibroin scaffold

Identifiers

PMID36248063
PMCPMC9540240
OpenAlexW4300960931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.